Biểu đồ giá cổ phiếu MNPR
MNPR Giá
Monopar Therapeutics Inc
$63.57
1.83%
$1.14
Khi đóng cửa: May 08, 16:00:00 GMT-4
$62.31
-1.98%
$-1.26
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
Monopar Therapeutics Inc (MNPR) Giá
Thống kê chính
Giá đóng cửa trước
$62.43
Giá mở cửa
$61.85
Phạm vi ngày
$61.56 - $65.57
Phạm vi 52 tuần
$28.4 - $105
Khối lượng
173.9K
Khối lượng trung bình
246.5K
Tỷ suất cổ tức
--
EPS (TTM)
-1.82
Vốn hóa thị trường
$416.8M
MNPR là gì?
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. The company is headquartered in Wilmette, Illinois and currently employs 16 full-time employees. The company went IPO on 2019-12-19. The firm developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.
